Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective Study

Autor: Muñoz-Gómez, Ana, Fernández-Cruz, Ana, Lavilla-Olleros, Cristina, Giner-Galvañ, Vicente, Ausín-García, Cristina, Wikman, Philip, Bendala-Estrada, Alejandro D., Vargas, Juan A., Rubio-Rivas, Manuel, Laureiro, Jaime, Fernández-Bermúdez, Daniel, Buonaiuto, Verónica A., Larriva, Antonio P. Arenas de, Pascual-Pérez, María de los Reyes, Alcalá-Pedrajas, José N., Ruiz, Ane Labirua-Iturburu, Hernández-Milián, Almudena, Mazo, Marta Gómez del, Antequera, Beatriz, Mella-Pérez, Carmen, Navas-Alcántara, María de la Sierra, Soto-Delgado, Juan F., Gámez-Mancera, Rosa M., Sardiña-González, Cristina, Meijide-Míguez, Héctor, Ramos-Rincón, José M., Gómez-Huelgas, Ricardo, Network, on behalf of the SEMI-COVID-19 Network on behalf of the SEMI-COVID-19

Publikováno v: Journal of Clinical Medicine
Volume 10
Issue 20
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine, Vol 10, Iss 4678, p 4678 (2021)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

We aimed to determine the impact of steroid use in COVID-19 in-hospital mortality, in a retrospective cohort study of the SEMICOVID19 database of admitted patients with SARS-CoV-2 laboratory-confirmed pneumonia from 131 Spanish hospitals. Patients tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f092ffeac0ce7787624e0eec0e4fd2

Mediterranean diet, neutrophil count, and carotid intima-media thickness in secondary prevention: the CORDIOPREV study.

Autor: Boughanem H; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Torres-Peña JD; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Arenas-de Larriva AP; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Romero-Cabrera JL; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Gómez-Luna P; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Martín-Piedra L; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Rodríguez-Cantalejo F; Biochemical Laboratory, Reina Sofia University Hospital, 14004 Córdoba, Spain., Tinahones FJ; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Malaga, Spain.; Institute of Biomedical Research in Malaga (IBIMA)-Bionand Platform, University of Malaga, 29590 Malaga, Spain., Yubero Serrano EM; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Soehnlein O; Institute of Experimental Pathology (ExPat), Center of Molecular Biology of Inflammation (ZMBE), University of Münster, 48149 Münster, Germany., Perez-Martinez P; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Delgado-Lista J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., López-Miranda J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain.; Department of Medical and Surgical Sciences, Universidad de Cordoba, 14004 Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), 14004 Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Publikováno v: European heart journal [Eur Heart J] 2024 Dec 11. Date of Electronic Publication: 2024 Dec 11.

Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study.

Autor: Garcia-Fernandez H; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Alcala-Diaz JF; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Quintana-Navarro GM; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Lopez-Moreno J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Luque-Cordoba D; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; Department of Analytical Chemistry and Nanochemistry University Institute, University of Cordoba, Cordoba, Spain.; CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain., Ruiz-Diaz Narvaez E; Department of Clinical Nutrition and Diet Therapy, Clinics Hospital, Faculty of Medical Sciences, National University of Asuncion, San Lorenzo, Paraguay., Arenas-de Larriva AP; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Gutierrez-Mariscal FM; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Torres-Peña JD; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Rodriguez-Cano D; Clinical Analysis Service, Reina Sofia University Hospital, Cordoba, Spain., Luque RM; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.; Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Cordoba, Spain., Priego-Capote F; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; Department of Analytical Chemistry and Nanochemistry University Institute, University of Cordoba, Cordoba, Spain.; Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Cordoba, Spain., Lopez-Miranda J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. jlopezmir@uco.es., Camargo A; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofía University Hospital, Cordoba, Spain.; Department of Medical and Surgical Sciences, University of Cordoba, Cordoba, Spain.; Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain.; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. antonio.camargo@imibic.org.

Publikováno v: The world journal of men's health [World J Mens Health] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.

Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial.

Autor: Podadera-Herreros A; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain., Arenas-de Larriva AP; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Gutierrez-Mariscal FM; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Alcala-Diaz JF; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Ojeda-Rodriguez A; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Rodriguez-Cantalejo F; Biochemical Laboratory, Reina Sofia University Hospital, 14004, Córdoba, Spain., Cardelo MP; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Rodriguez-Cano D; Biochemical Laboratory, Reina Sofia University Hospital, 14004, Córdoba, Spain., Torres-Peña JD; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Luque RM; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, University of Córdoba, 14004, Córdoba, Spain., Ordovas JM; Nutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, 02111, USA.; Precision Nutrition and Obesity Program, IMDEA Alimentación, 28049, Madrid, Spain., Perez-Martinez P; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Delgado-Lista J; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Lopez-Miranda J; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain., Yubero-Serrano EM; Unidad de Gestión Clinica Medicina Interna, Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Córdoba, Reina Sofia University Hospital, 14004 University of Córdoba, Córdoba, Spain. elena.yubero@imibic.org.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain. elena.yubero@imibic.org.

Publikováno v: Nutrition & diabetes [Nutr Diabetes] 2024 May 16; Vol. 14 (1), pp. 27. Date of Electronic Publication: 2024 May 16.

Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial.

Autor: Ojeda-Rodriguez A; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Rangel-Zuñiga OA; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Arenas-de Larriva AP; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Gutierrez-Mariscal FM; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Torres-Peña JD; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Romero-Cabrera JL; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Podadera-Herreros A; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., García-Fernandez H; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Porras-Pérez E; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Luque RM; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba, Cordoba, 14004, Spain., Kales SN; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Occupational Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA., Perez-Martinez P; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Delgado-Lista J; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Yubero-Serrano EM; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain., Lopez-Miranda J; Lipids and Atherosclerosis Unit, Internal Medicine Unit, Reina Sofia University Hospital, Cordoba, 14004, Spain. jlopezmir@uco.es.; Department of Medical and Surgical Science, University of Cordoba, Cordoba, 14004, Spain. jlopezmir@uco.es.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Av. Menendez Pidal, s/n, Cordoba, 14004, Spain. jlopezmir@uco.es.; CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, 28029, Spain. jlopezmir@uco.es.

Publikováno v: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Mar 16; Vol. 23 (1), pp. 98. Date of Electronic Publication: 2024 Mar 16.